India’s Bharat Biotech will be producing part of the world’s only malaria vaccine that has been developed by Pharma major GSK, and was recently approved by WHO (World Health Organisation). However, it may take a couple of years before the vaccine is launched in the market for use. In January, this year, Hyderabad-based vaccine major announced that it entered a product transfer partnership with the pharma major GSK for its malaria vaccine, RTS, S/AS01E1.As part of this partnership, GSK would transfer RTS manufacturing technology to Bharat Biotech to produce the S antigen component of the malaria vaccine, and the license on all rights pertaining to it. GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to Bharat Biotech.
Related Articles
Breaking News
Barrett, Gorsuch, Kavanaugh side with liberal Supreme Court justices in computer fraud case
WASHINGTON (TIP): Trump-appointed Supreme Court Justices Brett Kavanaugh, Amy Coney Barrett and Neil Gorsuch sided with liberal Justices Stephen Breyer, Sonia Sotomayor and Elena Kagan Thursday, June 3, to endorse a narrow approach on how […]
India
AAP MLA Amanatullah Khan arrested after raids in corruption case
New Delhi (TIP) AAP MLA Amanatullah Khan was arrested by the Anti-Corruption Branch, a unit of Delhi Police, on Friday. September 16, Amanatullah Khan was arrested following recovery of “incriminating material and evidence against him” […]
Entertainment
KANGANA: EVEN IF MY JOURNEY ENDS NOW, I HAVE NOTHING TO LOSE
Her over a decade-long journey in Bollywood has seen many a triumph, including her three National awards, and Kangana Ranaut said if her career ends now, she has nothing to lose as she has a huge success story for […]

Be the first to comment